Elan complete royalty rights deal
Irish pharmaceutical firm Elan has completed the acquisition of the royalty rights of three drugs from Pharma Operating.
Elan said this morning that it has completed the purchase of the rights in respect of Zonegran, Frova and Zanaflex for $99.6m (€83.75m).
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





